SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056724
Filing Date
2021-11-12
Accepted
2021-11-12 16:38:09
Documents
99
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q celu-10q_20210930.htm   iXBRL 10-Q 4139750
2 EX-10.25 celu-ex1025_196.htm EX-10.25 92742
3 EX-31.1 celu-ex311_6.htm EX-31.1 21159
4 EX-31.2 celu-ex312_9.htm EX-31.2 21156
5 EX-32.1 celu-ex321_8.htm EX-32.1 9304
6 EX-32.2 celu-ex322_7.htm EX-32.2 9375
  Complete submission text file 0001564590-21-056724.txt   16429742

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA celu-20210930.xsd EX-101.SCH 106346
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celu-20210930_cal.xml EX-101.CAL 64730
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20210930_def.xml EX-101.DEF 409014
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20210930_lab.xml EX-101.LAB 690806
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20210930_pre.xml EX-101.PRE 555609
12 EXTRACTED XBRL INSTANCE DOCUMENT celu-10q_20210930_htm.xml XML 3693224
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 211404230
SIC: 2834 Pharmaceutical Preparations